Izrael - hebrajski - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - docetaxel - תמיסה לאינפוזיה - docetaxel 10 mg / 1 ml - docetaxel - docetaxel - breast cancer: docetaxel in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node- positive breast cancer. docetaxel in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition. docetaxel monotherapy is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent. docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumors overexpress her2 and who previously have not received chemotherapy for metastatic disease. docetaxel in combination with capecitabine is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic chemotherapy. previous therapy should have included an anthracyclin

Izrael - hebrajski - Ministry of Health

abic marketing ltd - docetaxel 20 mg/ml - concentrate for solution for infusion - docetaxel - breast cancer: docetaxel in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node- positive breast cancer. docetaxel in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition. docetaxel monotherapy is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent. docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumors overexpress her2 and who previously have not received chemotherapy for metastatic disease.docetaxel in combination with capecitabine is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic chemotherapy. previous therapy should have included an anthracycline

Izrael - hebrajski - Ministry of Health

teva pharmaceutical industries ltd, israel - chlorpheniramine maleate - טבליה - chlorpheniramine maleate 2 mg - substituted alkylamines - symptomatic relief of perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild uncomplicated urticaria and angioedema, amelioration of allergic reactions to blood or plasma, dermatographism, adjunctive therapy in anaplylactic reactions.

Izrael - hebrajski - Ministry of Health

propharm ltd - dacarbazine - אבקה להמסה להזרקה\אינפוזיה - dacarbazine 200 mg/vial - other alkylating agents - for the treatment of metastatic malignant melanoma, hodgkin's disease as a second line therapy when used in combination with other agents.

Izrael - hebrajski - Ministry of Health

gamida care ltd., israel - ethanol; propanol - תמיסה - propanol 18 %w/v; ethanol 45 %w/v - propanol, combinations

Izrael - hebrajski - Ministry of Health

j-c healthcare ltd. - רופא - רדיולוגיה

Izrael - hebrajski - Ministry of Health

lavi industrial & medical agencies ltd. - רופא - אביזרים תומכי רפואה בתחום הדימות,רפואה גרעינית ורפואה פיזיקלית

Izrael - hebrajski - Ministry of Health

a.m.i. technologies, ltd. - אחות - סטריליזציה ושטיפת ציוד רפואי

Izrael - hebrajski - Ministry of Health

a.m.i. technologies, ltd. - רופא

Izrael - hebrajski - Ministry of Health

a.m.i. technologies, ltd. - רופא - ציוד לחדר ניתוח